HomeBUSINESS
BUSINESS

Kyowa Kirin Submits Regpara Successor in Japan
(Apr.28.2017)

Kyowa Hakko Kirin said on April 27 that it has filed a new drug application in Japan for novel calcimimetic agent evocalcet (development code: KHK7580) for the treatment of patients with secondary hyperparathyroidism on hemodialysis ...
(LOG IN FOR FULL STORY)

News Calendar